Mutations in the SLC22A12 gene are associated with diseases with abnormal serum uric acid levels, including hypouricemia (43, 44), hyperuricemia (45–47), gout (43, 45, 48), and nephrolithiasis (49). This evidence concerns the gene SLC22A12 and nephrolithiasis.